Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 18, 2023 08:00 ET | Source: BioAdaptives, Inc.

BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Bioavailable Resveratrol for Both Animals and Humans

LAS VEGAS, NV, April 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the signing of a non-exclusive license agreement with LY Research Corporation...
April 13, 2023 08:00 ET | Source: BioAdaptives, Inc.

BioAdaptives Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Visionary Futurist , Wellness Pioneer and Marketer, David Allen, PhD

LAS VEGAS, NV, April 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the appointment of David Allen, PhD to its Board of Directors. Edward Jacobs,...
March 30, 2023 08:00 ET | Source: BioAdaptives, Inc.

BioAdaptives Inc. Announced Today the Signing of a License for Eye Health due to Myopia and Presbyopia; a Patent Valued at US$ 570,000,000

LAS VEGAS, NV, March 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the signing of a second non-exclusive license agreement with LY Research...
March 28, 2023 08:00 ET | Source: BioAdaptives, Inc.

BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Product for Glucose Management

LY Research Patent # US 8,114,444 B2 is Valued at US$210,000,000 LAS VEGAS, NV, March 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts: BDPT) announced today the...